trending Market Intelligence /marketintelligence/en/news-insights/trending/hhe6cj7myp-en5jgkdz7ig2 content esgSubNav
In This List

Bridgepoint takes majority stake in French biotech company HTL

Blog

Post-webinar Q&A: Speed and Scalability – Automation in Credit Risk Modeling

Case Study

A Chinese Bank Takes Steps to Minimize Risks as it Supports International Trade

Blog

Middle East Africa MA by the Numbers: Q3 2021

Blog

Banking Essentials Newsletter: November Edition 2021 - Part 2


Bridgepoint takes majority stake in French biotech company HTL

Global private equity firm Bridgepoint bought a majority stake in HTL SAS, a French maker of hyaluronic acid and its byproducts, for an undisclosed sum.

Investment firm Naxicap Partners, which specializes in direct and fund of fund investments, sold the stake but will reinvest in HTL through a substantial minority interest.

Bridgepoint focuses on lower-middle-market buyouts and growth investments in small markets.